Efficacy and safety of SarogLItazar as an add-on medication to Metformin and lifestyle intervention in women with PolyCystic Ovary Syndrome (SLIM-PCOS trial): study protocol for a randomized, open-label, parallel group clinical trial. [PDF]
Mittal N, Singhal S, Mittal R.
europepmc +1 more source
Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad. [PDF]
Sinkey RG +6 more
europepmc +1 more source
Effect of nanoliposomal gamma-oryzanol on cryosurvival, oxidative balance, and fertility of frozen-thawed ram spermatozoa. [PDF]
Abbasi R +3 more
europepmc +1 more source
Saroglitazar for non-obese metabolic-dysfunction associated steatotic liver disease (MASLD): An open-label randomised controlled trial. [PDF]
Bhagat N +8 more
europepmc +1 more source
Impact of Elexacaftor-Tezacaftor-Ivacaftor on Gastrointestinal Symptoms, Intestinal Ultrasound, and Pancreatic Stiffness in Cystic Fibrosis. [PDF]
Fraquelli M +5 more
europepmc +1 more source
Reactions of 2-Formyl-3-methoxypropionitrile Derivatives as Electrophilic Reagent
Mamoru Tanaka, Y. Abe, Kanji Tokuyama
semanticscholar +1 more source
Brazilian Green Propolis and Essential Oil Residues Improve Metabolic Dysfunction by Modulating Key Hepatic Lipogenic Genes in High-Fat Diet-Fed Mice. [PDF]
Araújo CA +12 more
europepmc +1 more source
Chiglitazar in combination with anti-inflammatory and hepatoprotective therapy for the treatment of MASH associated with T2DM: a prospective, multicentre, randomised, double-blind, placebo-controlled study protocol. [PDF]
He K +21 more
europepmc +1 more source
Corn Oil Oleogel With γ-Oryzanol/β-Sitosterol: Structural, Thermal, Textural, and Oxidative Characterization. [PDF]
Elbir Abca T, Gençcelep H.
europepmc +1 more source

